Kazuo Ogawa
-
- Heart Failure Treatment and Management 20
- Cardiovascular Function and Risk Factors 19
- Cardiac Valve Diseases and Treatments 6
- Nephrology top 10%
-
- Cardiac Imaging and Diagnostics 8
-
- Lipid Membrane Structure and Behavior 7
-
- Antioxidant Activity and Oxidative Stress 7
- Eicosanoids and Hypertension Pharmacology 5
-
- Erythrocyte Function and Pathophysiology 6
- Co-authors
- Michihiro YoshimuraKosuke MinaiMakoto KawaiTakuma SaitoTomohisa NagoshiTakayuki OgawaYoshio BandoDmitri Golberg
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Kazuo Ogawa
109 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 120
- Cardiology and Cardiovascular Medicine 387
- Nephrology 77
- Internal Medicine 27
- Complementary and alternative medicine 57
- Endocrinology, Diabetes and Metabolism 111
Countries citing papers authored by Kazuo Ogawa
This map shows the geographic impact of Kazuo Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuo Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuo Ogawa more than expected).
Fields of papers citing papers by Kazuo Ogawa
This network shows the impact of papers produced by Kazuo Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuo Ogawa. The network helps show where Kazuo Ogawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kazuo Ogawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 1 | |
| 8 | 2019 | 7 | |
| 9 | 2019 | 9 | |
| 10 | 2017 | 14 | |
| 11 | 2017 | 12 | |
| 12 | 2015 | 24 | |
| 13 | High Incidence of Repeat Anginal Attacks Despite Treatment With Calcium-Channel Blockers in Patients With Coronary Spastic Angina(Ischemic Heart Disease) | 2009 | 2 |
| 14 | 2007 | 51 | |
| 15 | Clinical evaluation of benidipine hydrochloride (KW-3049) on angina pectoris: A double-blind comparative study with nifedipine | 1990 | 7 |
| 16 | 1989 | 7 | |
| 17 | AN ATTEMPT TO CLARIFY THE CONTROL MECHANISM OF AUTOPHAGY | 1987 | 1 |
| 18 | HYPOLIPIDEMIC ACTIVITY OF A NOVEL LIPASE INHIBITOR, FL-386 | 1987 | 1 |
| 19 | Ultracytochemical Study of Thiamine monophosphatase Activity on the Spinal Tract of the Trigeminal Nerve. | 1981 | 1 |
| 20 | Two Primary Melanomas of the Human Brain | 1979 | 2 |
About Kazuo Ogawa
Kazuo Ogawa is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Biochemistry, having authored 118 papers that have together received 1.2k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (20 papers), Cardiovascular Function and Risk Factors (19 papers), Cardiac Imaging and Diagnostics (8 papers), Lipid Membrane Structure and Behavior (7 papers), Antioxidant Activity and Oxidative Stress (7 papers), Erythrocyte Function and Pathophysiology (6 papers), Cardiac Valve Diseases and Treatments (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (387 citations), Nephrology (77 citations) and Internal Medicine (27 citations). Kazuo Ogawa has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Michihiro Yoshimura, Kosuke Minai, Makoto Kawai, Takuma Saito, Tomohisa Nagoshi, Takayuki Ogawa, Yoshio Bando, Dmitri Golberg, Kimiaki Komukai and S Kohno. Their work appears in journals such as PLoS ONE, Neurology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.